Literature DB >> 29744348

Treatment plan improvement by multidisciplinary case conferences for patients with colorectal cancer and synchronous liver metastases.

Markus Rentsch1, Tobias S Schiergens1.   

Abstract

Entities:  

Year:  2018        PMID: 29744348      PMCID: PMC5934124          DOI: 10.21037/hbsn.2018.03.05

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN: 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  4 in total

1.  Management of colorectal cancer with synchronous liver metastases: impact of multidisciplinary case conference review.

Authors:  Kerollos N Wanis; Karen Pineda-Solis; Mauro E Tun-Abraham; Jake Yeoman; Stephen Welch; Kelly Vogt; Julie Ann M Van Koughnett; Michael Ott; Roberto Hernandez-Alejandro
Journal:  Hepatobiliary Surg Nutr       Date:  2017-06       Impact factor: 7.293

Review 2.  Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus.

Authors:  René Adam; Aimery de Gramont; Joan Figueras; Norihiro Kokudo; Francis Kunstlinger; Evelyne Loyer; Graeme Poston; Philippe Rougier; Laura Rubbia-Brandt; Alberto Sobrero; Catherine Teh; Sabine Tejpar; Eric Van Cutsem; Jean-Nicolas Vauthey; Lars Påhlman
Journal:  Cancer Treat Rev       Date:  2015-06-30       Impact factor: 12.111

Review 3.  Multidisciplinary treatment of colorectal liver metastases.

Authors:  Tobias S Schiergens; Jobst von Einem; Michael N Thomas; Markus Albertsmeier; Clemens Giessen-Jung; Maximilian Dörsch; Christian Heiliger; Moritz Drefs; Joachim Andrassy; Dominik P Modest; Sebastian Stintzing; Markus Guba; Martin Angele; Jens Werner; Markus Rentsch
Journal:  Minerva Med       Date:  2017-09-08       Impact factor: 4.806

4.  A 10-year study of outcome following hepatic resection for colorectal liver metastases - The effect of evaluation in a multidisciplinary team setting.

Authors:  J T Lordan; N D Karanjia; N Quiney; W J Fawcett; T R Worthington
Journal:  Eur J Surg Oncol       Date:  2008-03-06       Impact factor: 4.424

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.